高分子量激肽原基因沉默對血管通透性的作用研究
首發時間:2025-09-24
徐琳亞,女,碩士研究生,血管穩態調控
陽艾珍 1 武藝 1武藝,男,博導,血栓與止血
摘要:本研究旨在構建人源化HK小鼠,并運用GalNAc-HK-siRNA肝靶向特異性基因沉默技術,減少血漿HK而根本性抑制BK產生,藉此研究在HAE小鼠模型靶向抑制HK降低血管通透性的作用。運用CRISPR/Cas9構建人源Kng1基因敲入小鼠;然后與鼠源Kng1敲除小鼠交配得到只有人源化Kng1小鼠,再使用皮下注射靶向HK (HK mRNA)的GalNAc-siRNA,檢測給藥后降低血漿HK效果;應用血管緊張素抑制劑誘導和芥子油誘導兩種不同的血管滲漏小鼠模型,評估HK基因沉默緩解血管通透性的作用。人源化Kng1小鼠遺傳表型正常,具有正常的FXIIa和PKa酶活性。單次皮下注射3 mg/kg劑量的GalNAc-HK-siRNA導致血漿人HK mRNA減少70%以上,血漿人HK蛋白減少95%以上。在緩激肽驅動的血管滲漏的兩種不同疾病模型中,GalNAc-HK-siRNA給藥后表現為劑量依賴性的降低血管通透性,表明RNAi介導的血漿HK的降低下調BK的產生,減輕緩激肽所致的血管通透性增加。提示RNAi介導的GalNAc-HK-siRNA敲低HK是一種潛在的有效治療HAE的方法。
關鍵詞: 遺傳性血管性水腫 GalNAc-siRNA 高分子量激肽原 緩激肽 血管通透性
For information in English, please click here
The effect of High-Molecular-Weight Kininogen Gene Silencing on Vascular Permeability
徐琳亞,女,碩士研究生,血管穩態調控
YANG Aizhen 1 WU Yi 1武藝,男,博導,血栓與止血
Abstract:This study aims to construct humanized HK mice and use GalNAc-HK-siRNA liver-targeted specific gene silencing technology to reduce plasma HK and fundamentally inhibit BK production, so as to investigate the effect of targeted inhibition of HK on reducing vascular permeability in HAE mouse models.CRISPR/Cas9 technology was used to construct human Kng1 knock-inmice; then, these mice were mated with mouse Kng1 knockout mice to obtain mice with only humanized Kng1. Subsequently, GalNAc-siRNA targeting HK (HK mRNA) was administered via subcutaneous injection to detect the effect of reducing plasma HK after administration. Two different vascular leakage mouse models induced by angiotensin inhibitors and mustard oil were applied to evaluate the role of HK gene silencing in alleviating vascular permeability.Humanized Kng1 mice exhibited a normal genetic phenotype. They also had normal FXIIa and PKa enzymatic activities. A single subcutaneous injection of GalNAc-HK-siRNA at a dose of 3 mg/kg resulted in a reduction of more than 70% in plasma human HK mRNA and over 95% in plasma human HK protein. In two different disease models of bradykinin-driven vascular leakage, administration of GalNAc-HK-siRNA led to a dose-dependent decrease in vascular permeability, indicating that RNAi-mediated reduction of plasma HK downregulates the production of BK and alleviates bradykinin-induced increase in vascular permeability. These results suggest that RNAi-mediated knockdown of HK by GalNAc-HK-siRNA is a potentially effective therapeutic approach for HAE.
Keywords: Hereditary angioedema;GalNAc-siRNA;High-molecular-weight kininogen;Bradykinin Vascular permeability
基金:
引用

No.****
動態公開評議
共計0人參與
勘誤表
高分子量激肽原基因沉默對血管通透性的作用研究
評論
全部評論